Scott Giacobello

Chief Financial OfficeratWhitehawk Therapeutics· In proxies 2022–2025

Pay in FY2025+163% from the year before · Whitehawk Therapeutics stock -23.3% the same year

Scott Giacobello was paid $2.1M in FY2025 (Dec), up 163%. Whitehawk Therapeutics stock fell 23.3% that year.

Pay$100 in the stock at the end of FY21 → $10

Pay is from the Summary Compensation Table of each Whitehawk Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

WHWK
Whitehawk TherapeuticsPublic company · 4 yr
- Chief Financial Officer2022 – Present · 4 yrStock in role -86%

Roles come from the proxy statements of each company.

Activity

Pay
Whitehawk Therapeutics CFO pay rose 163% to $2.1M. The stock fell 23% in FY2025 (Dec).
DEF 14AApr 28, 2026
Pay
Whitehawk Therapeutics CFO pay fell 59% to $807.9K. The stock rose 56% in FY2024 (Dec).
DEF 14AApr 28, 2025
Pay
Whitehawk Therapeutics CFO pay rose 31% to $2.0M. The stock fell 84% in FY2023 (Dec).
DEF 14AApr 26, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?